127 related articles for article (PubMed ID: 1939785)
1. Analysis of HMB-45 immunoreactivity in common and cellular blue nevi.
Wood WS; Tron VA
J Cutan Pathol; 1991 Aug; 18(4):261-3. PubMed ID: 1939785
[TBL] [Abstract][Full Text] [Related]
2. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation.
Skelton HG; Smith KJ; Barrett TL; Lupton GP; Graham JH
Am J Dermatopathol; 1991 Dec; 13(6):543-50. PubMed ID: 1725245
[TBL] [Abstract][Full Text] [Related]
3. Congenital agminated Spitz nevi: immunoreactivity with a melanoma-associated monoclonal antibody.
Palazzo JP; Duray PH
J Cutan Pathol; 1988 Jun; 15(3):166-70. PubMed ID: 3397410
[TBL] [Abstract][Full Text] [Related]
4. Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study.
Palazzo J; Duray PH
Hum Pathol; 1989 Apr; 20(4):341-6. PubMed ID: 2703228
[TBL] [Abstract][Full Text] [Related]
5. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
6. Antibody HMB-45 identifies the cells of blue nevi. An immunohistochemical study on paraffin sections.
Sun J; Morton TH; Gown AM
Am J Surg Pathol; 1990 Aug; 14(8):748-51. PubMed ID: 2378395
[TBL] [Abstract][Full Text] [Related]
7. Compound melanocytic nevi with granular cell changes.
El-Gamal HM; Robinson-Bostom L; Saddler KD; Pan T; Mihm MC
J Am Acad Dermatol; 2004 May; 50(5):765-6. PubMed ID: 15097962
[TBL] [Abstract][Full Text] [Related]
8. Oral melanocytic lesions: differences in expression of HMB-45 and S-100 antigens in round and spindle cells of malignant and benign lesions.
Gazit D; Daniels TE
J Oral Pathol Med; 1994 Feb; 23(2):60-4. PubMed ID: 8164154
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
10. HMB-45 antibody reactivity in pigmented lesions of the conjunctiva.
Glasgow BJ; McCall LC; Foos RY
Am J Ophthalmol; 1990 Jun; 109(6):696-700. PubMed ID: 2189315
[TBL] [Abstract][Full Text] [Related]
11. SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions.
Trefzer U; Rietz N; Chen Y; Audring H; Herberth G; Siegel P; Reinke S; Königer P; Wu S; Ma J; Liu Y; Wang H; Sterry W; Guo Y
Arch Dermatol Res; 2000 Dec; 292(12):583-9. PubMed ID: 11214818
[TBL] [Abstract][Full Text] [Related]
12. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.
McNutt NS; Urmacher C; Hakimian J; Hoss DM; Lugo J
J Cutan Pathol; 1995 Dec; 22(6):502-17. PubMed ID: 8835170
[TBL] [Abstract][Full Text] [Related]
13. HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups.
Ahmed I; Piepkorn M; Goldgar DE; Cannon-Albright LA; Meyer LJ; Skolnick MH; Zone JJ
J Cutan Pathol; 1991 Aug; 18(4):257-60. PubMed ID: 1939784
[TBL] [Abstract][Full Text] [Related]
14. Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma, neural tumors and nevi.
Shah IA; Gani OS; Wheler L
Pathol Res Pract; 1997; 193(7):497-502. PubMed ID: 9342756
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
Kopera D; Hohenleutner U; Stolz W; Landthaler M
Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
[TBL] [Abstract][Full Text] [Related]
16. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
[TBL] [Abstract][Full Text] [Related]
17. HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein.
Smoller BR; Hsu A; Krueger J
J Cutan Pathol; 1991 Oct; 18(5):315-22. PubMed ID: 1761783
[TBL] [Abstract][Full Text] [Related]
18. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
Sexton M; Sexton CW
Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
[TBL] [Abstract][Full Text] [Related]
19. S100A6 protein expression is different in Spitz nevi and melanomas.
Ribé A; McNutt NS
Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
[TBL] [Abstract][Full Text] [Related]
20. Compound blue nevus: a variant of blue nevus with an additional junctional dendritic component. A clinical, histopathologic, and immunohistochemical study of six cases.
Kamino H; Tam ST
Arch Dermatol; 1990 Oct; 126(10):1330-3. PubMed ID: 2221938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
